These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3946946)

  • 1. Effect of doxepin on basal gastric acid and salivary secretion in patients with duodenal ulcer.
    Brown-Cartwright D; Brater DC; Barnett CC; Richardson CT
    Ann Intern Med; 1986 Feb; 104(2):204-6. PubMed ID: 3946946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two antimuscarinic drugs, pirenzepine and propantheline, on gastric acid secretion, serum gastrin concentration, salivary flow and heart rate in patients with duodenal ulcer disease.
    Richardson CT; Barnett CC; Walsh JH; Feldman M
    Aliment Pharmacol Ther; 1987 Aug; 1(4):281-91. PubMed ID: 2979673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
    Leitold M; Fleissig W; Merk A
    Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of doxepin on gastric secretion in man.
    Giercksky KE; Oyen D; Andersen OK; Burhol P
    Scand J Gastroenterol; 1984 Jul; 19(5):661-4. PubMed ID: 6433435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxepin therapy for duodenal ulcer: a controlled trial in patients who failed to respond to cimetidine.
    Shrivastava RK; Siegal H; Lawlor R; Shah BK; Dayican G
    Clin Ther; 1985; 7(3):319-26. PubMed ID: 3888393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxepin and cimetidine in the treatment of duodenal ulcer: an open clinical and endoscopic study.
    Ruud TE; Hoff GS; Tonder M; Holter O
    J Clin Psychiatry; 1982 Aug; 43(8 Pt 2):56-60. PubMed ID: 7096279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimoprostil plasma concentration-gastric acid inhibition relationships in duodenal ulcer patients.
    Wills RJ; O'Leary A; Givens SV; Scheinbaum ML
    J Clin Pharmacol; 1986 Jan; 26(1):48-54. PubMed ID: 3950051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of smoking on gastric acid secretion in patients with duodenal ulcer.
    Ramesh GN; Kochhar R; Broor SL; Ghosh P; Sharma BK; Mehta SK
    J Gastroenterol Hepatol; 1989; 4(3):259-63. PubMed ID: 2491152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxepin in the treatment of duodenal ulcer. A double-blind clinical study comparing doxepin and placebo.
    Andersen OK; Bergsåker-Aspøy J; Halvorsen L; Giercksky KE
    Scand J Gastroenterol; 1984 Oct; 19(7):923-5. PubMed ID: 6397849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric acid and pancreatic polypeptide responses to modified sham feeding: indication of an increased basal vagal tone in a subgroup of duodenal ulcer patients.
    Kohn A; Annibale B; Suriano G; Severi C; Spinella S; Delle Fave G
    Gut; 1985 Aug; 26(8):776-82. PubMed ID: 4018642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients.
    Colturi TJ; Unger RH; Feldman M
    J Clin Invest; 1984 Aug; 74(2):417-23. PubMed ID: 6146638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sham feeding on gastric acid secretion in healthy subjects and duodenal ulcer patients: evidence for increased basal vagal tone in some ulcer patients.
    Feldman M; Richardson CT; Fordtran JS
    Gastroenterology; 1980 Nov; 79(5 Pt 1):796-800. PubMed ID: 7419002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.
    de Gara CJ; Burget DW; Silletti C; Hunt RH
    Am J Gastroenterol; 1987 Jan; 82(1):36-41. PubMed ID: 3099564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxepin and cimetidine in the treatment of duodenal ulcer: a double-blind comparative study.
    Shrivastava RK; Shah BK; Siegal H
    Clin Ther; 1985; 7(2):181-9. PubMed ID: 3886141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transdermal scopolamine, alone or in combination with cimetidine, on total 24 hour gastric acid secretion in patients with duodenal ulcer.
    Richardson CT; Feldman M
    Gut; 1986 Dec; 27(12):1493-7. PubMed ID: 3804025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age does not affect basal gastric acid secretion in normal subjects or in patients with acid-peptic disease.
    Collen MJ; Abdulian JD; Chen YK
    Am J Gastroenterol; 1994 May; 89(5):712-6. PubMed ID: 8172143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat inhibition of gastric acid secretion in duodenal ulcer patients before and after proximal gastric vagotomy.
    Kihl B; Olbe L
    Gut; 1980 Dec; 21(12):1056-61. PubMed ID: 7007174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin induced inhibition of gastric acid secretion in duodenal ulcer patients before and after parietal cell vagotomy.
    Olsen PS; Pedersen JH; Kirkegaard P; Been H; Stadil F; Fahrenkrug J; Christiansen J
    Gut; 1984 May; 25(5):481-4. PubMed ID: 6714791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal and sham-feeding-stimulated salivary flow in duodenal ulcer patients and healthy subjects.
    Richardson CT; Feldman M
    Scand J Gastroenterol; 1988 Aug; 23(6):765-8. PubMed ID: 3262916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the synthetic PGE1 derivative misoprostol on basal, stimulated and nocturnal acid secretion in duodenal ulcer cases. Mechanism of action.
    Buzás G; Puscas I; Persa F; Reznicek A
    Acta Physiol Hung; 1989; 73(2-3):185-91. PubMed ID: 2512765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.